Calcitonin gene-related peptide (CGRP) plays a pivotal role in the pathophysiology of migraine and is an important therapeutic target. Monoclonal antibodies that inhibit CGRP binding to its receptor ...

Migraine Is a Brain Disease Although the pathogenesis of migraine — or how the disease develops — is not completely clear, it’s believed to be caused by a complex interaction among your genes, the ...

SAN DIEGO — Migraine is the third most common neurological disorder worldwide, and yet reliable treatments remain elusive. Research hinting at new avenues for treatments will be presented at ...

Novel formulation of intranasal oxytocin contains magnesium (Mg2+), shown to potentiate the analgesic effects of oxytocin on the oxytocin receptor in animal models TNX-1900 blocks release of CGRP, a ...

Menstrual migraine (MM) refers to migraine headaches associated with menstruation, which have been shown to occur in 22% to 70% of patients with migraine. MM attacks typically last longer and are more ...

In a paper published in the May issue of JAMA, M. S. Robbins, of Weill Cornell Medical College, reviews the diagnosis, prevention, and treatment of primary headaches. In a previous post, I discussed ...